FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.5892
+0.0144 (2.51%)
At close: Aug 13, 2025, 4:00 PM
0.5880
-0.0012 (-0.20%)
Pre-market: Aug 14, 2025, 7:37 AM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $24.68 million as of August 14, 2025. Its market cap has decreased by -86.26% in one year.
Market Cap
24.68M
Enterprise Value
26.61M
1-Year Change
-86.26%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $24.68M, a decrease of -97.39%. That is a compound annual growth rate of -90.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 24.68M | -64.83% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 571.40B |
| Johnson & Johnson | 420.26B |
| AbbVie | 350.38B |
| UnitedHealth Group | 232.46B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |